UNC13A
Basic information
Region (hg38): 19:17601336-17688365
Links
Phenotypes
GenCC
Source:
- congenital nervous system disorder (Limited), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (130 variants)
- UNC13A-related_disorder (124 variants)
- not_provided (103 variants)
- Neurodevelopmental_disorder (3 variants)
- UNC13A-related_Neurodevelopmental_and_Movement_disorder (3 variants)
- Tremor (2 variants)
- Amyotrophic_lateral_sclerosis (2 variants)
- Cerebellar_ataxia (2 variants)
- Amyotrophic_lateral_sclerosis_type_1 (1 variants)
- UNC13A-related_Neurodevelopmental_disorder (1 variants)
- Microcephaly (1 variants)
- Delayed_speech_and_language_development (1 variants)
- UNC13A-associated_disorder (1 variants)
- Febrile_seizure_(within_the_age_range_of_3_months_to_6_years) (1 variants)
- Developmental_regression (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the UNC13A gene is commonly pathogenic or not. These statistics are base on transcript: NM_001080421.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 78 | 12 | 90 | |||
missense | 185 | 196 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 10 | |||||
splice donor/acceptor (+/-2bp) | 5 | |||||
Total | 1 | 2 | 202 | 86 | 13 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
UNC13A | protein_coding | protein_coding | ENST00000519716 | 44 | 87265 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 4.01e-10 | 125167 | 0 | 29 | 125196 | 0.000116 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 5.63 | 513 | 1.02e+3 | 0.504 | 0.0000641 | 11229 |
Missense in Polyphen | 174 | 467.09 | 0.37252 | 4933 | ||
Synonymous | -0.0310 | 428 | 427 | 1.00 | 0.0000311 | 3085 |
Loss of Function | 8.39 | 9 | 99.1 | 0.0908 | 0.00000513 | 1103 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000942 | 0.000938 |
Ashkenazi Jewish | 0.0000998 | 0.0000993 |
East Asian | 0.0000556 | 0.0000545 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000443 | 0.0000441 |
Middle Eastern | 0.0000556 | 0.0000545 |
South Asian | 0.0000999 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in vesicle maturation during exocytosis as a target of the diacylglycerol second messenger pathway. Involved in neurotransmitter release by acting in synaptic vesicle priming prior to vesicle fusion and participates in the activity-dependent refilling of readily releasable vesicle pool (RRP). Essential for synaptic vesicle maturation in most excitatory/glutamatergic but not inhibitory/GABA-mediated synapses (By similarity). Also involved in secretory granule priming in insulin secretion (By similarity). Interacts with FBXO45 (via SRY domain); leading to the degradation of UNC13A by the proteasome (By similarity). Plays a role in dendrite formation by melanocytes (PubMed:23999003). {ECO:0000250, ECO:0000269|PubMed:23999003}.;
- Pathway
- Synaptic vesicle cycle - Homo sapiens (human);Synaptic Vesicle Pathway
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- -1.7
- rvis_percentile_EVS
- 2.58
Haploinsufficiency Scores
- pHI
- 0.207
- hipred
- Y
- hipred_score
- 0.623
- ghis
- 0.621
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.875
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Unc13a
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- positive regulation of neurotransmitter secretion;neurotransmitter secretion;neuromuscular junction development;synaptic vesicle docking;synaptic vesicle priming;synaptic vesicle maturation;positive regulation of synaptic plasticity;synaptic transmission, glutamatergic;intracellular signal transduction;regulation of short-term neuronal synaptic plasticity;amyloid-beta metabolic process;regulation of synaptic transmission, glutamatergic;innervation;dense core granule priming;presynaptic dense core vesicle exocytosis;positive regulation of glutamate receptor signaling pathway;regulation of amyloid precursor protein catabolic process;positive regulation of dendrite extension
- Cellular component
- plasma membrane;cell junction;synaptic vesicle membrane;neuromuscular junction;presynaptic membrane;neuron projection;terminal bouton;calyx of Held;presynaptic active zone;presynaptic active zone cytoplasmic component;glutamatergic synapse
- Molecular function
- calcium ion binding;calmodulin binding;phospholipid binding;syntaxin-1 binding;diacylglycerol binding